首页|以骨肉瘤形态为主的原发性恶性骨巨细胞瘤7例临床病理分析

以骨肉瘤形态为主的原发性恶性骨巨细胞瘤7例临床病理分析

扫码查看
目的 探讨以骨肉瘤形态为主原发性恶性骨巨细胞瘤(primary malignant giant cell tumor of bone,PMGCTB)的临床病理学特征.方法 回顾性分析7例PMGCTB的临床病理特征.结果 7例PMGCTB中,女性4例,男性3例,年龄9~66岁(平均39.5岁,中位年龄35岁).发生部位以股骨骨端最常见(3/6),临床表现为病变部位的疼痛和肿胀.影像学表现为溶骨性占位、溶骨和硬化混合性占位为主;多数骨皮质破坏伴软组织肿块形成(5/7).组织学均以普通型骨肉瘤形态为主,破骨细胞样多核巨细胞完全消失或少量存在.免疫表型:6例肿瘤细胞H3F3A G34W核阳性、1例H3F3A G34V核阳性,所有肿瘤均表达SATB2、p63,p53呈野生型,Ki67增殖指数10%~50%.所有病例均发现H3F3A基因改变,6例为H3F3A p.G34W突变,1例为H3F3A p.G34V突变.结论 PMGCTB罕见,当缺乏经典骨巨细胞瘤组织学特征时诊断更具挑战性,需结合影像学、免疫表型及分子检测,并注意与骨肉瘤及其他高级别肉瘤相鉴别.
Primary malignant giant cell tumor of bone with predominant osteosarcoma morphology:a clinicopathological analysis of seven cases
Purpose To elucidate the clinicopathological characteristics of primary malignant giant cell tumor of bone(PMGCTB)with mainly osteosarcoma-like morphology.Meth-ods Clinicopathologic features of 7 cases of PMGCTB were ret-rospectively analyzed.Results Among 7 patients with PMGCTB,there were 4 females and 3 males,aged between 9 and 66 years(mean age 39.5 years,median age 35 years).The distal femur emerged as the most frequent site to be involved(3/6).The main clinical manifestations included pain and swelling at the original site of the tumor.Radiological findings indicated osteolytic lesions,often combined with sclerotic areas;most ca-ses showed cortical bone destruction and soft tissue masses(5/7).Histologically,the majority of tumors exhibited typical mor-phological features of osteosarcoma with a few or without osteo-clast-like multinucleated giant cells.Positive immunoreaction with H3F3A G34W was confirmed in 6 cases and with H3F3A G34V in 1 case.SATB2 and p63 were positive in all cases,p53 was proved to be wild type,the Ki67 proliferation index ranged approximately from 10%to 50%.H3F3A p.G34W mutation was detected in 6 cases and only 1 case harboring H3F3A p.G34V mutation.Conclusion PMGCTB is exceedingly rare and difficult for accurate diagnosis,especially for those with atypical morphological features.A comprehensive analysis involving ra-diological,immunophenotypic,and molecular detection is neces-sary to rule out other high-grade sarcomas.

malignant giant cell tumor of boneosteosarcomaH3F3A

蒋婷、周隽、陈春燕、庞艳蕊、沈岚、陈杰、刘志艳

展开 >

上海交通大学医学院附属第六人民医院病理科,上海 200233

上海交通大学医学院附属第六人民医院骨与软组织肿瘤综合诊治中心,上海 200233

南方医科大学深圳医院病理科,深圳 518000

恶性骨巨细胞瘤 骨肉瘤 H3F3A

国家自然科学基金上海市2023年度"科技创新行动计划"自然科学基金上海市2020年度"科技创新行动计划"医学创新研究专项

8197250023ZR144820020Z11900304

2024

临床与实验病理学杂志
安徽医科大学,中华医学会安徽分会

临床与实验病理学杂志

CSTPCD北大核心
影响因子:0.776
ISSN:1001-7399
年,卷(期):2024.40(8)